Tag Archives: CTL-X

Veritas Enrolls First Patient in Clinical Study to Assess Pain Control with Lead Product

Feb. 22, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Puerto Rico LLC, a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), today announced the dosing of the first adult volunteer in its clinical trial of their lead cannabis product (“CTL-X”) for the treatment of acute pain.

Veritas Confirms Readiness for Human Trials of CTL-X for Pain; Projected to Start Early Next Month

Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it is now preparing to commence human trials to test its lead cannabis product

Veritas’ Cannevert to Offer Testing Services for Cannabis & Hemp Licensed Producers; Corporate Update

Sept. 19, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to provide a corporate update on its activities, milestones over the first three quarters of 2018, and strategies for growth in the new year.